Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Celia Requena

Showing results (121-130 of 148) with videos related to

Pageof 15
Sort By:
Scientific Reports|December 16, 2018
Author Correction: Telomere length and survival in primary cutaneous melanoma patientsSivaramakrishna Rachakonda, Nalini Srinivas, Seyed Hamidreza Mahmoudpour, et al.
Scientific Reports|July 21, 2018
Telomere length and survival in primary cutaneous melanoma patientsSivaramakrishna Rachakonda, Nalini Srinivas, Seyed Hamidreza Mahmoudpour, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 28, 2026
Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody-drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and VenereologyMargarita Majem, Kevin Molina Mata, Ander Mayor Ibarguren, et al.
Cancers|August 14, 2025
Integration of an OS-Based Machine Learning Score (AS Score) and Immunoscore as Ancillary Tools for Predicting Immunotherapy Response in SarcomasIsidro Machado, Raquel López-Reig, Eduardo Giner, et al.
Cancers|August 12, 2023
Topographical and Chronological Analysis of Thin Cutaneous Melanoma's Progressions: A Multicentric StudyEmmanouil Chousakos, Daniela Zugna, Emi Dika, et al.
American Journal of Clinical Pathology|March 9, 2023
Tumor Microenvironment and Its Clinicopathologic and Prognostic Association in Cutaneous and Noncutaneous AngiosarcomasIsidro Machado, Celia Requena, Raquel López-Reig, et al.
Melanoma Research|June 16, 2026
Melanocortin-1 receptor variants and telomerase reverse transcriptase promoter mutations as prognostic biomarkers in stage IIB-IIC melanomaMarcella Scala, David Lorente-Estellés, Luigi Liguori, et al.
International Journal of Cancer|February 15, 2016
TERT promoter mutations in melanoma survivalEduardo Nagore, Barbara Heidenreich, Sívaramakrishna Rachakonda, et al.
Journal of the American Academy of Dermatology|April 15, 2011
Chemotherapy-related bilateral dermatitis associated with eccrine squamous syringometaplasia: reappraisal of epidemiological, clinical, and pathological featuresAntonio Martorell-Calatayud, Onofre Sanmartín, Rafael Botella-Estrada, et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|January 18, 2021
[Protocol for the histologic diagnosis of cutaneous melanoma: consensus statement of the Spanish Society of Pathology and the Spanish Academy of Dermatology and Venereology (AEDV) for the National Cutaneous Melanoma Registry]Antonio Tejera-Vaquerizo, María Teresa Fernández-Figueras, Ángel Santos-Briz, et al.
Pageof 15

Showing results (121-130 of 148) with videos related to

Sort By:
Pageof 15
Scientific Reports|December 16, 2018
Author Correction: Telomere length and survival in primary cutaneous melanoma patientsSivaramakrishna Rachakonda, Nalini Srinivas, Seyed Hamidreza Mahmoudpour, et al.
Scientific Reports|July 21, 2018
Telomere length and survival in primary cutaneous melanoma patientsSivaramakrishna Rachakonda, Nalini Srinivas, Seyed Hamidreza Mahmoudpour, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 28, 2026
Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody-drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and VenereologyMargarita Majem, Kevin Molina Mata, Ander Mayor Ibarguren, et al.
Cancers|August 14, 2025
Integration of an OS-Based Machine Learning Score (AS Score) and Immunoscore as Ancillary Tools for Predicting Immunotherapy Response in SarcomasIsidro Machado, Raquel López-Reig, Eduardo Giner, et al.
Cancers|August 12, 2023
Topographical and Chronological Analysis of Thin Cutaneous Melanoma's Progressions: A Multicentric StudyEmmanouil Chousakos, Daniela Zugna, Emi Dika, et al.
American Journal of Clinical Pathology|March 9, 2023
Tumor Microenvironment and Its Clinicopathologic and Prognostic Association in Cutaneous and Noncutaneous AngiosarcomasIsidro Machado, Celia Requena, Raquel López-Reig, et al.
Melanoma Research|June 16, 2026
Melanocortin-1 receptor variants and telomerase reverse transcriptase promoter mutations as prognostic biomarkers in stage IIB-IIC melanomaMarcella Scala, David Lorente-Estellés, Luigi Liguori, et al.
International Journal of Cancer|February 15, 2016
TERT promoter mutations in melanoma survivalEduardo Nagore, Barbara Heidenreich, Sívaramakrishna Rachakonda, et al.
Journal of the American Academy of Dermatology|April 15, 2011
Chemotherapy-related bilateral dermatitis associated with eccrine squamous syringometaplasia: reappraisal of epidemiological, clinical, and pathological featuresAntonio Martorell-Calatayud, Onofre Sanmartín, Rafael Botella-Estrada, et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|January 18, 2021
[Protocol for the histologic diagnosis of cutaneous melanoma: consensus statement of the Spanish Society of Pathology and the Spanish Academy of Dermatology and Venereology (AEDV) for the National Cutaneous Melanoma Registry]Antonio Tejera-Vaquerizo, María Teresa Fernández-Figueras, Ángel Santos-Briz, et al.
Pageof 15